United States Genotropin Market Report 2016

November 2016 | 102 pages | ID: UC1E3FCB579EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Genotropin

Revenue, means the sales value of Genotropin

This report studies sales (consumption) of Genotropin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Eli Lilly and Company (US)
• Ferring Holding SA (Switzerland)
• Genentech, Inc. (US)
• GeneScience Pharmaceuticals Co., Ltd. (China)
• Merck Serono SA (Switzerland)
• Novo Nordisk A/S (Denmark)
• Pfizer, Inc. (US)
• Sandoz International GmbH (Germany)
• Teva Pharmaceutical Industries Limited (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Genotropin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Genotropin Market Report 2016

1 GENOTROPIN OVERVIEW

1.1 Product Overview and Scope of Genotropin
1.2 Classification of Genotropin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Genotropin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Genotropin (2011-2021)
  1.4.1 United States Genotropin Sales and Growth Rate (2011-2021)
  1.4.2 United States Genotropin Revenue and Growth Rate (2011-2021)

2 UNITED STATES GENOTROPIN COMPETITION BY MANUFACTURERS

2.1 United States Genotropin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Genotropin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Genotropin Average Price by Manufactures (2015 and 2016)
2.4 Genotropin Market Competitive Situation and Trends
  2.4.1 Genotropin Market Concentration Rate
  2.4.2 Genotropin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GENOTROPIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Genotropin Sales and Market Share by Type (2011-2016)
3.2 United States Genotropin Revenue and Market Share by Type (2011-2016)
3.3 United States Genotropin Price by Type (2011-2016)
3.4 United States Genotropin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES GENOTROPIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Genotropin Sales and Market Share by Application (2011-2016)
4.2 United States Genotropin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES GENOTROPIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Eli Lilly and Company (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Genotropin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Eli Lilly and Company (US) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Ferring Holding SA (Switzerland)
  5.2.2 Genotropin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Ferring Holding SA (Switzerland) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Genentech, Inc. (US)
  5.3.2 Genotropin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Genentech, Inc. (US) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GeneScience Pharmaceuticals Co., Ltd. (China)
  5.4.2 Genotropin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Merck Serono SA (Switzerland)
  5.5.2 Genotropin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Merck Serono SA (Switzerland) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novo Nordisk A/S (Denmark)
  5.6.2 Genotropin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novo Nordisk A/S (Denmark) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Pfizer, Inc. (US)
  5.7.2 Genotropin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer, Inc. (US) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Sandoz International GmbH (Germany)
  5.8.2 Genotropin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Sandoz International GmbH (Germany) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Teva Pharmaceutical Industries Limited (Israel)
  5.9.2 Genotropin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Teva Pharmaceutical Industries Limited (Israel) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 GENOTROPIN MANUFACTURING COST ANALYSIS

6.1 Genotropin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Genotropin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Genotropin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Genotropin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES GENOTROPIN MARKET FORECAST (2016-2021)

10.1 United States Genotropin Sales, Revenue Forecast (2016-2021)
10.2 United States Genotropin Sales Forecast by Type (2016-2021)
10.3 United States Genotropin Sales Forecast by Application (2016-2021)
10.4 Genotropin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genotropin
Table Classification of Genotropin
Figure United States Sales Market Share of Genotropin by Type in 2015
Table Application of Genotropin
Figure United States Sales Market Share of Genotropin by Application in 2015
Figure United States Genotropin Sales and Growth Rate (2011-2021)
Figure United States Genotropin Revenue and Growth Rate (2011-2021)
Table United States Genotropin Sales of Key Manufacturers (2015 and 2016)
Table United States Genotropin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genotropin Sales Share by Manufacturers
Figure 2016 Genotropin Sales Share by Manufacturers
Table United States Genotropin Revenue by Manufacturers (2015 and 2016)
Table United States Genotropin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Genotropin Revenue Share by Manufacturers
Table 2016 United States Genotropin Revenue Share by Manufacturers
Table United States Market Genotropin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Genotropin Average Price of Key Manufacturers in 2015
Figure Genotropin Market Share of Top 3 Manufacturers
Figure Genotropin Market Share of Top 5 Manufacturers
Table United States Genotropin Sales by Type (2011-2016)
Table United States Genotropin Sales Share by Type (2011-2016)
Figure United States Genotropin Sales Market Share by Type in 2015
Table United States Genotropin Revenue and Market Share by Type (2011-2016)
Table United States Genotropin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Genotropin by Type (2011-2016)
Table United States Genotropin Price by Type (2011-2016)
Figure United States Genotropin Sales Growth Rate by Type (2011-2016)
Table United States Genotropin Sales by Application (2011-2016)
Table United States Genotropin Sales Market Share by Application (2011-2016)
Figure United States Genotropin Sales Market Share by Application in 2015
Table United States Genotropin Sales Growth Rate by Application (2011-2016)
Figure United States Genotropin Sales Growth Rate by Application (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (US) Genotropin Sales Market Share (2011-2016)
Table Ferring Holding SA (Switzerland) Basic Information List
Table Ferring Holding SA (Switzerland) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ferring Holding SA (Switzerland) Genotropin Sales Market Share (2011-2016)
Table Genentech, Inc. (US) Basic Information List
Table Genentech, Inc. (US) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech, Inc. (US) Genotropin Sales Market Share (2011-2016)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information List
Table GeneScience Pharmaceuticals Co., Ltd. (China) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Genotropin Sales Market Share (2011-2016)
Table Merck Serono SA (Switzerland) Basic Information List
Table Merck Serono SA (Switzerland) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Serono SA (Switzerland) Genotropin Sales Market Share (2011-2016)
Table Novo Nordisk A/S (Denmark) Basic Information List
Table Novo Nordisk A/S (Denmark) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk A/S (Denmark) Genotropin Sales Market Share (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer, Inc. (US) Genotropin Sales Market Share (2011-2016)
Table Sandoz International GmbH (Germany) Basic Information List
Table Sandoz International GmbH (Germany) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz International GmbH (Germany) Genotropin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Limited (Israel) Basic Information List
Table Teva Pharmaceutical Industries Limited (Israel) Genotropin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Limited (Israel) Genotropin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genotropin
Figure Manufacturing Process Analysis of Genotropin
Figure Genotropin Industrial Chain Analysis
Table Raw Materials Sources of Genotropin Major Manufacturers in 2015
Table Major Buyers of Genotropin
Table Distributors/Traders List
Figure United States Genotropin Production and Growth Rate Forecast (2016-2021)
Figure United States Genotropin Revenue and Growth Rate Forecast (2016-2021)
Table United States Genotropin Production Forecast by Type (2016-2021)
Table United States Genotropin Consumption Forecast by Application (2016-2021)